*** Thursday, March 11, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET *** How can CROs continue to grow in today’s increasingly competitive market? Learn how you can turn client experience into your competitive advantage. *** On demand available after final airing until Mar. 11, 2022 ***
This article sets out a vision of adopting convenient alternative blood sampling approaches that places the needs of the patient at the center and enables active monitoring, before the onset of clinical events, leading to improved healthcare.
eTMF-blockchain technology offers a myriad of application benefits to data quality and integrity while ensuring compliance to ethical standards.
A more user-centered design can allow increased flexibility in the development of eCOA platforms, driving better engagement and participation.
Implementing centralized risk-based monitoring can help meet strict GCP requirements for study conduct, oversight, and recording.
Insights from Bayer’s study review process showcases importance of incorporating feedback from a wider audience of stakeholders.
Identifying KPIs, benchmarks, key data points, and an actionable plan are all keys to accelerating study start-up cycles.
New protocols, remote patient monitoring, and improved standards of care among ways industry can take next steps in CAR T-cell research.
Key takeaways from a survey of 250 oncology patients measuring COVID-19’s impact on patient willingness to participate in clinical trials.
Keys to ensuring your clinical trials better reflect your target population.
Laboratory services organization focuses on easing patient and site burden with improved collection device.
Trials that address multiple questions simultaneously using a master protocol can be operationally complicated. These complexities can be managed, even in studies used to support a marketing application.
As drug development costs continue to escalate, sponsors are incentivized to find less expensive approaches to develop their assets. FSP models provide increased operational and resourcing flexibility and different pricing plans in comparison to traditional full-service CRO offerings.
Natural language processing models are able to automate the extraction of pertinent information from a vast array of scientific literature.
Automating process can reduce time and resources lost from using manual steps and allows stakeholders to maintain compliance.
Now that the industry has gotten some experience with CDISC standards, teams are aiming to get more from their standardization efforts.
Laboratory services organization focuses on easing patient and site burden with improved collection device.
New and renewed approaches to improve chances of success in developing non-addictive drugs for chronic pain.
Exploring their unique opportunity in increasing study enrollment levels.
While Case Report Forms are a main contributor to collected data, non-CRF data such as core laboratory data and central imaging can be critical to any clinical study.
Despite repeated calls from the FDA, patient advocates, and scholars for the need to address demographic disparities in clinical research, White participants still remain overrepresented while racial minority participants remain underrepresented in clinical trials.
First-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.
eTMF-blockchain technology offers a myriad of application benefits to data quality and integrity while ensuring compliance to ethical standards.
Industry now leveraging reporting system to empower patients and improve research.
Tufts Center for the Study of Drug Development and Biogen recently conducted a study to inform growing interest in improving diversity of clinical trial participation. The results of this research provide insights into increasing the community of minority investigators and study staff and presenting greater access to clinical trials among minority study volunteers.